Law360, New York (January 2, 2014, 5:56 PM EST) -- A New York federal judge scrapped a False Claims Act suit accusing Roche Diagnostics Corp. of indirectly defrauding Medicare by failing to address glitches in its laboratory devices, finding Monday that a whistleblower's allegations of bogus billing were too murky.
The ruling, which also weighed in on a budding controversy surrounding the FCA's public disclosure bar, found that while Roche devices may have exaggerated the number of tests performed, there was no evidence of the federal government actually being charged for services that weren't provided.
U.S. District Judge Arthur D. Spatt acknowledged that a more lenient pleading standard is sometimes appropriate...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!